Pharmaceutical Executive-11-01-2021

In It For the Long-Haul: Planning for the Future of COVID-19

November 09, 2021

Features

While pharma has reached new heights in vaccine development, many questions remain around the lasting effects of COVID and how future therapies can curb them.

Turning the Corner: A New Era of Pharma Sales Comes Into View

November 09, 2021

Features

It wasn’t long before sales reps realized they needed a new strategy to keep prospect pools flowing—18 months later, a mix of in-person and virtual meetings with healthcare professionals is emerging as the preferred approach moving forward.

An Industry Under Attack: Pharma Revisits Cybersecurity During COVID-19

November 09, 2021

Features

Pharma organizations have long been vigilant in protecting their intellectual property and financial information, but the disruption of COVID-19 has seen an expansion of the ‘cyberattack surface.’

The New COVID Workforce: Keeping Pharma Strong Through Adversity

November 09, 2021

Features

How an increased focus on people has helped companies survive the pandemic.

Crafting Cures

November 09, 2021

Executive Profile

Moderna Chief Medical Officer Paul Burton looks to build on culture of innovation and speed to advance COVID-19 vaccine and develop new therapies based on its novel mRNA platform, spreading hope to patients around the world.

Could 2022 Prove to Be Better Year for Biotech Companies?

November 09, 2021

Finance

Regulatory headwinds are poised to ease as new year approaches.

Agencies Need Holistic Approach in Creating Value for HCPs, Patients

November 09, 2021

Marketing

New age of drug marketing must consider market access.

COVID and the Data Talent Turnabout

November 09, 2021

Technology

Traditionally difficult in pharma, data science recruitment witnessed a sharp drop-off at the beginning of the pandemic, but interest has since bounced back to unexpected levels.